From: Evaluating differential developmental trajectories to adolescent-onset mood and psychotic disorders
 | ANX-DEP | MAN-FAT | DEV-PSY | Significance test |
---|---|---|---|---|
 | (n = 310) | (n = 152) | (n = 143) | χ2 or ANOVA(2,df) [p] |
Comorbidity | Â | Â | Â | Â |
ADHD | 13% (40/310) | 11% (17/152) | 24% (34/143) | 12.4 [.015] |
Autistic spectrum disorders | 7% (20/310) | 3% (5/152) | 6% (8/143) | 2.0 [.371] |
Substance use | Â | Â | Â | Â |
Comorbid substance misuse | 37% (115/310) | 44% (67/152) | 41% (59/143) | 2.3 [.313] |
Age first nicotine [% cases = users] | 14.8 ± 2.5 [56%] | 14.6 ± 3.1 [67%] | 14.8 ± 2.8 [69%] | F (291) = 0.2 [.850] |
Age first alcohol [% cases = users] | 14.7 ± 2.4 [78%] | 14.4 ± 2.2 [87%] | 14.6 ± 3.3 [79%] | F (181.5) = 0.4 [.642] |
Age first cannabis [% cases = users] | 15.6 ± 2.3 [50%] | 15.3 ± 2.7 [60%] | 15.3 ± 2.4 [56%] | F (260) = 0.4 [.674] |
Family History | Â | Â | Â | Â |
Depression (n/N) | 56% (129/231) | 54% (65/120) | 24% (27/112) | 33.1 [.000] |
Anxiety (n/N) | 22% (51/231) | 34% (41/120) | 14% (16/112) | 13.2 [.001] |
Bipolar (n/N) | 12% (27/231) | 28% (34/120) | 7% (8/112) | 24.3 [.000] |
Schizophrenia (n/N) | 7% (17/231) | 18% (22/120) | 23% (26/112) | 18.2 [.000] |
Substance misuse (n/N) | 21% (49/231) | 30% (36/120) | 25% (28/112) | 3.3 [.189] |
Suicide (n/N) | 6% (15/231) | 4% (5/120) | 6% (7/112) | 0.8 [.672] |